<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363153">
  <stage>Registered</stage>
  <submitdate>15/10/2012</submitdate>
  <approvaldate>22/10/2012</approvaldate>
  <actrnumber>ACTRN12612001123831</actrnumber>
  <trial_identification>
    <studytitle>Frozen Shoulder Treatments  Conservative Approach Study Evaluation (FroST-CASE)</studytitle>
    <scientifictitle>Does receiving regular physiotherapy intervention in frozen shoulder adults affect the rate of change in range of motion and pain?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Acute to subacute adhesive capsulitis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Physiotherapy</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Rheumatoid arthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Electrical / heat therapy: Therapeutic ultrasound and/or hot pack.
Mobilisation techniques: Manual therapy - Grade III/IV caudal and/or anteroposterior glide(s) with/without combined movements.
Home exercise programme: Progressive range of motion (ROM) exercises.
Patient education on frozen shoulder and management rationale.
These interventions occur in every session.
1 x 30 minutes session per every 2 weeks for 6-12 weeks. Participant who's outcome improvements has stayed in status quo for 2 successive sessions (earlier than 12 weeks) will be considered by the treating physiotherapist to have completed the trial.
Mode: one-on-one sessions with physiotherapist.</interventions>
    <comparator>Electrical therapy: Therapeutic ultrasound
Mobilisation techniques: Manual therapy.
Home exercise programme: Progressive ROM exercises.
Follow-up based on earliest available appointment, 
1 x 20 minutes session per every 3 weeks for 6-12 weeks.
This active-control has shorter intervention time and patient education.</comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Shoulder range of motion (flexion, abduction, internal /external rotation, hand behind neck and hand behind back) measured with goniometer and prominent bony landmarks.</outcome>
      <timepoint>every 2 weeks up to 12th week or earlier (outcomes plateaued and exit from outpatient musculoskeletal service)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Pain numeric 10-point Likert-scale</outcome>
      <timepoint>every 2 weeks up to 12th week or earlier (outcomes plateaued and exit from outpatient musculoskeletal service)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Community dwelling adults
Diagnosed acute (3 months) and sub-acute (6 months) frozen shoulder</inclusivecriteria>
    <inclusiveminage>35</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Significant cognitive disorder
Fracture in healing phase
Cerebral haemorrhage and surgery within the past 3 months
Uncontrolled medical condition</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients are diagnosed by the medical doctors and referred for physiotherapy management. They are allocated a physiotherapist at random by appointment administrators (unaware of the trial).</concealment>
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/11/2012</anticipatedstartdate>
    <actualstartdate>3/04/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>20/03/2014</actualenddate>
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>National Healthcare Group Polyclinics</primarysponsorname>
    <primarysponsoraddress>6 Commonwealth Lane #07-01/02
GMTI Building
S(149547)</primarysponsoraddress>
    <primarysponsorcountry>Singapore</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Nil</fundingname>
      <fundingaddress>Unfunded</fundingaddress>
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the study is to investigate the outcomes of regular conservative physiotherapy management for frozen shouder population.
This study hypothesize that participants recieving regular physiotherapy management recovers faster and have better outcomes.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate>14/03/2013</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>17/10/2012</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Kwok Boon Chong</name>
      <address>6 Commonwealth Lane #07-01/02
GMTI Building
S(149547)</address>
      <phone>+65, 68962289</phone>
      <fax />
      <email>kwokboonchong@gmail.com</email>
      <country>Singapore</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Kwok Boon Chong</name>
      <address>6 Commonwealth Lane #07-01/02
GMTI Building
S(149547)</address>
      <phone>+65, 68962289</phone>
      <fax />
      <email>kwokboonchong@gmail.com</email>
      <country>Singapore</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Kwok Boon Chong</name>
      <address>National Healthcare Group Polyclinics
3 Fusionpolis Link, Nexus@one-north
Singapore 138543</address>
      <phone>+65 6896 2289</phone>
      <fax />
      <email>kwokboonchong@gmail.com</email>
      <country>Singapore</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>